Hepatitis Clinical Trials in Houston

Showing 281-281 of 281 trials

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

NCT00044135

The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.

Hepatitis B

Triangle Pharmaceuticals30 participantsStarted Aug 2002

Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States • Vancouver, Canada +8 more locations

PreviousPage 15 of 15

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis Trials in Other Cities

Other Conditions in Houston